Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
2289.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
-30%
0.31
vs 0.45
Q4.20
+571%
0.11
vs -0.02
Q2.21
-8%
0.29
vs 0.31
Q4.21
N/A
-0.03
vs 0.11
Q2.22
-22%
0.22
vs 0.29
Q4.22
+2412%
0.74
vs -0.03
Q2.23
+18%
0.26
vs 0.22
Q4.23
-65%
0.26
vs 0.74
Q2.24
+1%
0.27
vs 0.26
Q4.24
+2%
0.26
vs 0.26
Sales Growth
YoY
Current
Estimates
Q2.20
+9%
1.9B vs 1.7B
Q4.20
+19%
2.1B vs 1.8B
Q2.21
+7%
2B vs 1.9B
Q4.21
-15%
1.8B vs 2.1B
Q2.22
-5%
1.9B vs 2B
Q4.22
+27%
2.3B vs 1.8B
Q2.23
+20%
2.3B vs 1.9B
Q4.23
-7%
2.1B vs 2.3B
Q2.24
+3%
2.3B vs 2.3B
Q4.24
-2%
2.1B vs 2.1B
Return on Equity
QoQ
Q2.21
+5%
0.05
vs 0.02
Q4.21
-1%
-0.01
vs 0.05
Q2.22
+4%
0.04
vs -0.01
Q4.22
+12%
0.12
vs 0.04
Q2.23
+5%
0.05
vs 0.12
Q4.23
+4%
0.04
vs 0.05
Q2.24
+5%
0.05
vs 0.04
Q4.24
NA
NA
vs 0.05
Institutionnal Ownership
Quote Panel
Key Metrics
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.
HKSE
Relative Strenght
Volume Buzz
69%
Earning Acce
Yes
Dist 52w H.
31%Relative Strength
2289.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
118%2025-Revenue
110%2025-EPS
67%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 2289.HK compares to sector?